New treatment for acute myeloid leukaemia developed
July 7th, 2009 - 4:29 pm ICT by ANIWashington, July 7 (ANI): Australian and Canadian researchers have developed a new therapy that specifically targets cancer stem cells in acute myeloid leukaemia.
The new treatment targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome.
In the study led by Dr. Richard Lock in Australia, the researchers showed that antibodies targeting cancer stem cells significantly reduced the growth of human AML cells that had been transplanted into immune-deficient mice, mimicking the human disease.
Principle investigator of the study Dr. John Dick, senior scientist at the Ontario Cancer Institute, had previously shown that there is a population of cells within cancer, termed cancer stem cells, which are responsible for sustaining cancer growth.
The antibody targets the CD123 protein (IL-3 receptor a chain) on the cancer stem cells that drive cancer growth.
However, it does not appear to affect normal blood cells. On the basis of this experimental work, a Phase I clinical trial has been initiated to test safety and effectiveness in patients. (ANI)
- Bioengineered protein may help fight leukemia - Feb 19, 2011
- Novel targeted therapy shows promise to eliminate leukaemia stem cells - Jul 03, 2009
- Vicious circle' may offer novel acute leukemia treatment target - Apr 14, 2010
- Life work culminates in testing of cancer therapy in humans - Mar 24, 2011
- Gene mutation behind onset of acute myeloid leukaemia identified - Mar 28, 2011
- New therapeutic target for leukaemia identified - Jan 28, 2010
- Mouse genome offers human cancer clue - Mar 24, 2011
- New study shows evidence of stem cells' pivotal role in cancer - Dec 22, 2010
- New therapy shows promise in treating advanced leukemia - Nov 06, 2009
- Small molecule may deactivate enemy of cancer-fighting p53 - Dec 08, 2010
- 'Lion King' musical star Shannon Tavares dies at age 11 - Nov 03, 2010
- How loss of key protein promotes aggressive form of leukaemia - Jul 02, 2010
- Novel approach for leukaemia treatment discovered - Mar 04, 2010
- Arsenic could be a potential cancer treatment - Jul 13, 2010
- Just a handful of genetic changes behind childhood acute myeloid leukaemia - Jul 28, 2009
Tags: acute myeloid leukemia, aggressive disease, antibodies, antibody, blood cells, canadian researchers, cancer growth, clinical trial, deficient mice, dr john, dr richard, experimental work, john dick, leukemia aml, myeloid leukaemia, normal blood, ontario cancer institute, poor outcome, principle investigator, stem cells